Coenzyme A biosynthesis: an antimicrobial drug target

Date

2008

Authors

Spry, Christina
Kirk, Kiaran
Saliba, Kevin

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Pantothenic acid, a precursor of coenzyme A (CoA), is essential for the growth of pathogenic microorganisms. Since the structure of pantothenic acid was determined, many analogues of this essential metabolite have been prepared. Several have been demonstrated to exert an antimicrobial effect against a range of microorganisms by inhibiting the utilization of pantothenic acid, validating pantothenic acid utilization as a potential novel antimicrobial drug target. This review commences with an overview of the mechanisms by which various microorganisms acquire the pantothenic acid they require for growth, and the universal CoA biosynthesis pathway by which pantothenic acid is converted into CoA. A detailed survey of studies that have investigated the inhibitory activity of analogues of pantothenic acid and other precursors of CoA follows. The potential of inhibitors of both pantothenic acid utilization and biosynthesis as novel antibacterial, antifungal and antimalarial agents is discussed, focusing on inhibitors and substrates of pantothenate kinase, the enzyme catalysing the rate-limiting step of CoA biosynthesis in many organisms. The best strategies are considered for identifying inhibitors of pantothenic acid utilization and biosynthesis that are potent and selective inhibitors of microbial growth and that may be suitable for use as chemotherapeutic agents in humans.

Description

Keywords

Keywords: acyl carrier protein; antifungal agent; antiinfective agent; cj 15801; coenzyme A; dexpanthenol; homopantoyltaurine; methylpantethine; methylpantothenone; pantetheine phosphate; pantothenic acid; pantothenic acid 4' phosphate; pantoylhydrazide; pantoyltau Bacteria; Coenzyme A; Fungi; Malaria; Pantothenate kinase; Pantothenic acid

Citation

Source

FEMS Microbiology Reviews

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

Restricted until

2037-12-31